MA55891A - Synthèses en phase liquide convergente d'oligonucléotides - Google Patents

Synthèses en phase liquide convergente d'oligonucléotides

Info

Publication number
MA55891A
MA55891A MA055891A MA55891A MA55891A MA 55891 A MA55891 A MA 55891A MA 055891 A MA055891 A MA 055891A MA 55891 A MA55891 A MA 55891A MA 55891 A MA55891 A MA 55891A
Authority
MA
Morocco
Prior art keywords
oligonucleotides
liquid phase
phase syntheses
convergent
convergent liquid
Prior art date
Application number
MA055891A
Other languages
English (en)
Inventor
Firoz Antia
Yannick Fillon
Robert S Gronke
Takuya Hamagaki
Taisuke Ichimaru
Hong Jiang
William F Kiesman
Hien Nguyen
Xianglin Shi
Daisuke Takahashi
Wuming Yan
Xuan Zhou
Original Assignee
Ajinomoto Kk
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk, Biogen Ma Inc filed Critical Ajinomoto Kk
Publication of MA55891A publication Critical patent/MA55891A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA055891A 2019-05-08 2020-05-08 Synthèses en phase liquide convergente d'oligonucléotides MA55891A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962845160P 2019-05-08 2019-05-08

Publications (1)

Publication Number Publication Date
MA55891A true MA55891A (fr) 2022-03-16

Family

ID=70919104

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055891A MA55891A (fr) 2019-05-08 2020-05-08 Synthèses en phase liquide convergente d'oligonucléotides

Country Status (13)

Country Link
US (1) US12378276B2 (fr)
EP (1) EP3966219A2 (fr)
JP (2) JP7824080B2 (fr)
KR (1) KR20220007104A (fr)
CN (3) CN119143828A (fr)
AU (1) AU2020268415B2 (fr)
BR (1) BR112021022219A2 (fr)
CA (1) CA3139545A1 (fr)
EA (1) EA202193010A1 (fr)
IL (2) IL287798B2 (fr)
MA (1) MA55891A (fr)
MX (1) MX2021013587A (fr)
WO (1) WO2020227618A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2831232A4 (fr) 2012-03-30 2015-11-04 Univ Washington Procédés de modulation de l'expression de tau pour réduire l'avc et modifier un symptôme neurodégénératif
TW202246503A (zh) 2013-07-19 2022-12-01 美商百健Ｍａ公司 用於調節τ蛋白表現之組合物
KR20230106665A (ko) 2020-11-11 2023-07-13 바이오젠 엠에이 인코포레이티드 올리고뉴클레오티드, 시약, 및 그의 제조 방법
TW202310854A (zh) * 2021-07-23 2023-03-16 美商百健Ｍａ公司 用於減少ｔａｕ表現之方法
WO2024083746A1 (fr) 2022-10-17 2024-04-25 Bachem Holding Ag Procédé et composition pour la synthèse d'oligonucléotides
WO2024089953A1 (fr) * 2022-10-27 2024-05-02 住友化学株式会社 Procédé de production d'oligonucléotide
JPWO2024185775A1 (fr) 2023-03-06 2024-09-12
GB202305283D0 (en) * 2023-04-11 2023-05-24 Exactmer Ltd Liquid-phase process for preparing oligonucleotides
JP7433684B1 (ja) * 2023-05-24 2024-02-20 塩野フィネス株式会社 疑似固相保護基、それを用いたヌクレオシド保護体又はオリゴヌクレオチド保護体、オリゴアミダイト前駆体の製造方法
EP4695265A1 (fr) 2023-10-16 2026-02-18 Bachem Holding AG Procédé et composition pour la synthèse d'oligonucléotides
US20250206769A1 (en) * 2023-12-22 2025-06-26 Imec Vzw Synthesizing a Nucleic Acid or Nucleic Acid Analogue
WO2025235761A1 (fr) 2024-05-09 2025-11-13 Biogen Ma Inc. Réactifs et procédés de préparation d'oligonucléotides
WO2026085433A2 (fr) 2024-10-17 2026-04-23 Biogen Ma Inc. Procédés pour préparer des conjugués oligonucléotidiques

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096658A1 (fr) 1990-11-20 1992-05-21 Sankyo Company, Limited Derive d'acide nucleique
US5510476A (en) 1994-07-07 1996-04-23 Isis Pharmaceuticals, Inc. Carbocation scavenging during oligonucleotide synthesis
AU738032B2 (en) 1995-10-19 2001-09-06 Proligo Llc Method for solution phase synthesis of oligonucleotides
EP1386925A1 (fr) * 2002-07-31 2004-02-04 Girindus AG Procédé de préparation des oligonucleotides
EP3470072A1 (fr) 2005-06-23 2019-04-17 Biogen MA Inc. Compositions et procédés pour modulation de l'épissage du smn2
CN102282155B (zh) 2008-12-02 2017-06-09 日本波涛生命科学公司 磷原子修饰的核酸的合成方法
JP5548852B2 (ja) 2009-05-29 2014-07-16 国立大学法人東京農工大学 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法
ES2699827T3 (es) 2009-06-17 2019-02-13 Biogen Ma Inc Composiciones y métodos para la modulación de corte y empalme de SMN2 en un sujeto
US20120184724A1 (en) * 2009-09-22 2012-07-19 Agilent Technologies, Inc. Protected monomers and methods of deprotection for rna synthesis
JP5705512B2 (ja) 2010-11-26 2015-04-22 農工大ティー・エル・オー株式会社 高分散性液相支持体を用いたオリゴヌクレオチド合成法
DK2711370T3 (en) * 2011-05-17 2018-02-26 Ajinomoto Kk PROCEDURE FOR THE PREPARATION OF OLIGONUCLEOTIDES
US8846885B2 (en) 2012-02-17 2014-09-30 Ajinomoto Co., Inc. Oligonucleotide with protected base
EP2816053B1 (fr) 2012-02-17 2021-03-24 Ajinomoto Co., Inc. Oligonucléotide ayant une base protégée
US9284344B2 (en) * 2012-05-30 2016-03-15 Hokkaido System Science Co., Ltd. Oligonucleotide synthesis method using highly dispersible liquid-phase support
US10214555B2 (en) * 2012-11-14 2019-02-26 Takeda Pharmaceutical Company Limitjed Method for liquid-phase synthesis of nucleic acid
HUE050704T2 (hu) 2014-04-01 2020-12-28 Biogen Ma Inc Összetételek a SOD-1 expressziójának modulálására
CN113717239B (zh) 2015-01-21 2024-12-24 味之素株式会社 沉淀促进剂以及使用其的沉淀方法
CN116063365A (zh) 2015-12-16 2023-05-05 味之素株式会社 寡核苷酸的制备方法以及核苷、核苷酸或寡核苷酸
WO2017111137A1 (fr) * 2015-12-22 2017-06-29 味の素株式会社 Procédé de production d'oligonucléotides
AU2016381992B2 (en) 2015-12-28 2024-01-04 Chugai Seiyaku Kabushiki Kaisha Method for promoting efficiency of purification of Fc region-containing polypeptide
TW201906855A (zh) 2017-05-02 2019-02-16 日商日產化學工業股份有限公司 寡核苷酸之製造方法

Also Published As

Publication number Publication date
US12378276B2 (en) 2025-08-05
WO2020227618A2 (fr) 2020-11-12
AU2020268415A8 (en) 2022-01-20
IL287798A (en) 2022-01-01
JP2025138846A (ja) 2025-09-25
AU2020268415A1 (en) 2021-12-23
EA202193010A1 (ru) 2022-03-18
CN114206897B (zh) 2024-09-20
CN114206897A (zh) 2022-03-18
IL287798B2 (en) 2025-09-01
IL319933A (en) 2025-05-01
BR112021022219A2 (pt) 2022-03-22
CN119462804A (zh) 2025-02-18
WO2020227618A8 (fr) 2020-12-24
JP7824080B2 (ja) 2026-03-04
IL287798B1 (en) 2025-05-01
CA3139545A1 (fr) 2020-11-12
KR20220007104A (ko) 2022-01-18
WO2020227618A3 (fr) 2021-01-14
AU2020268415B2 (en) 2026-04-23
EP3966219A2 (fr) 2022-03-16
US20220348602A1 (en) 2022-11-03
MX2021013587A (es) 2022-02-11
CN119143828A (zh) 2024-12-17
JP2022531876A (ja) 2022-07-12

Similar Documents

Publication Publication Date Title
MA55891A (fr) Synthèses en phase liquide convergente d'oligonucléotides
IL286487A (en) Technologies useful for oligonucleotide preparation
MA51066A (fr) Inhibiteurs d'intégrine
EP3953668A4 (fr) Procédé d'étalonnage pour débitmètre de liquide
EP3484908A4 (fr) Supports solides non nucléosides et blocs de construction de phosphoramidite pour synthèse d'oligonucléotides
EP3360534A4 (fr) Produit cosmétique d'écran solaire pouvant être pulvérisé
IL284441A (en) One pot synthesis of sets of oligonucleotides
EP3601604A4 (fr) Détection multiple d'anticorps spécifiques à un isotype
EP3871998A4 (fr) Réservoir d'azote liquide
EP3391953A4 (fr) Générateur d'écoulement tourbillonnant pour une séparation gaz-liquide
EP3815571A4 (fr) Récipient de produit cosmétique liquide à distribution par rotation
FR3046038B1 (fr) Module de support de sac a dos pour une structure modulaire d'exosquelette
EP3438121A4 (fr) Procédé de synthèse en phase liquide d'oxytocine à l'aide de polypeptides
EP3590188A4 (fr) Respect de temps d'établissement/de maintien pour un signal répétitif concernant une horloge
EP3834809A4 (fr) Produit cosmétique à base d'huile
EP4073032A4 (fr) Synthèse chimique en flux d'isocyanates
EP4059711A4 (fr) Revêtement liquide
MA51795A (fr) Oligonucléotides pour moduler l'expression de tmem106b
EP3756700A4 (fr) Composition d'agent embolique liquide
EP3620035A4 (fr) Procédés et systèmes pour former un revêtement liquide d'une cavité
FR3074700B1 (fr) Systeme pour la distribution d'une phase liquide et/ou gazeuse dans une enceinte reactionnelle
MA52148A (fr) Peptides chimères pour administration d'antisens
EP4021996A4 (fr) Compositions d'encre électrophotographique liquide
MA49278A (fr) Oligonucléotides antisens pour moduler l'expression de htra1
EP3650455A4 (fr) Procédé de synthèse d'acide nucléique en phase solide et composition liquide pour la synthèse d'acide nucléique en phase solide